151 related articles for article (PubMed ID: 31778724)
1. The globus pallidus as a target for neuropeptides and endocannabinoids participating in central activities.
Chen XY; Xue Y; Chen H; Chen L
Peptides; 2020 Feb; 124():170210. PubMed ID: 31778724
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoid (CB(1)), GABA(A) and GABA(B) receptor subunit changes in the globus pallidus in Huntington's disease.
Allen KL; Waldvogel HJ; Glass M; Faull RL
J Chem Neuroanat; 2009 Jul; 37(4):266-81. PubMed ID: 19481011
[TBL] [Abstract][Full Text] [Related]
3. Orexin-A increases the activity of globus pallidus neurons in both normal and parkinsonian rats.
Xue Y; Yang YT; Liu HY; Chen WF; Chen AQ; Sheng Q; Chen XY; Wang Y; Chen H; Liu HX; Pang YY; Chen L
Eur J Neurosci; 2016 Sep; 44(5):2247-57. PubMed ID: 27336845
[TBL] [Abstract][Full Text] [Related]
4. GABAergic neurotransmission in globus pallidus and its involvement in neurologic disorders.
Chen L; Yung WH
Sheng Li Xue Bao; 2004 Aug; 56(4):427-35. PubMed ID: 15322674
[TBL] [Abstract][Full Text] [Related]
5. Evidence for a preferential loss of enkephalin immunoreactivity in the external globus pallidus in low grade Huntington's disease using high resolution image analysis.
Sapp E; Ge P; Aizawa H; Bird E; Penney J; Young AB; Vonsattel JP; DiFiglia M
Neuroscience; 1995 Jan; 64(2):397-404. PubMed ID: 7535402
[TBL] [Abstract][Full Text] [Related]
6. The comparative distribution of enkephalin, dynorphin and substance P in the human globus pallidus and basal forebrain.
Haber SN; Watson SJ
Neuroscience; 1985 Apr; 14(4):1011-24. PubMed ID: 2582307
[TBL] [Abstract][Full Text] [Related]
7. Neurochemical substrates of rigidity and chorea in Huntington's disease.
Storey E; Beal MF
Brain; 1993 Oct; 116 ( Pt 5)():1201-22. PubMed ID: 7693298
[TBL] [Abstract][Full Text] [Related]
8. Immunocytochemical studies of substance P and leucine-enkephalin in Huntington's disease.
Marshall PE; Landis DM; Zalneraitis EL
Brain Res; 1983 Dec; 289(1-2):11-26. PubMed ID: 6198034
[TBL] [Abstract][Full Text] [Related]
9. Regulation of dopamine receptor and neuropeptide expression in the basal ganglia of monkeys treated with MPTP.
Betarbet R; Greenamyre JT
Exp Neurol; 2004 Oct; 189(2):393-403. PubMed ID: 15380489
[TBL] [Abstract][Full Text] [Related]
10. Effects of exogenous and endogenous cannabinoids on GABAergic neurotransmission between the caudate-putamen and the globus pallidus in the mouse.
Engler B; Freiman I; Urbanski M; Szabo B
J Pharmacol Exp Ther; 2006 Feb; 316(2):608-17. PubMed ID: 16214880
[TBL] [Abstract][Full Text] [Related]
11. Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease.
Di Marzo V; Hill MP; Bisogno T; Crossman AR; Brotchie JM
FASEB J; 2000 Jul; 14(10):1432-8. PubMed ID: 10877836
[TBL] [Abstract][Full Text] [Related]
12. Dopamine-opiate interaction in the regulation of neostriatal and pallidal neuronal activity as assessed by opioid precursor peptides and glutamate decarboxylase messenger RNA expression.
Mavridis M; Besson MJ
Neuroscience; 1999; 92(3):945-66. PubMed ID: 10426535
[TBL] [Abstract][Full Text] [Related]
13. Early effects of intrastriatal injections of quinolinic acid on microtubule-associated protein-2 and neuropeptides in rat basal ganglia.
Bordelon YM; Chesselet MF
Neuroscience; 1999; 93(3):843-53. PubMed ID: 10473250
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous mass spectrometry imaging of multiple neuropeptides in the brain and alterations induced by experimental parkinsonism and L-DOPA therapy.
Hulme H; Fridjonsdottir E; Gunnarsdottir H; Vallianatou T; Zhang X; Wadensten H; Shariatgorji R; Nilsson A; Bezard E; Svenningsson P; Andrén PE
Neurobiol Dis; 2020 Apr; 137():104738. PubMed ID: 31927144
[TBL] [Abstract][Full Text] [Related]
15. Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's disease.
Albin RL; Reiner A; Anderson KD; Dure LS; Handelin B; Balfour R; Whetsell WO; Penney JB; Young AB
Ann Neurol; 1992 Apr; 31(4):425-30. PubMed ID: 1375014
[TBL] [Abstract][Full Text] [Related]
16. Electrophysiological and behavioral effects of neurotensin in rat globus pallidus: an in vivo study.
Xue Y; Chen L; Cui QL; Xie JX; Yung WH
Exp Neurol; 2007 May; 205(1):108-15. PubMed ID: 17362935
[TBL] [Abstract][Full Text] [Related]
17. Orexins alleviate motor deficits via increasing firing activity of pallidal neurons in a mouse model of Parkinson's disease.
Wang Y; Chen AQ; Xue Y; Liu MF; Liu C; Liu YH; Pan YP; Diao HL; Chen L
Am J Physiol Cell Physiol; 2019 Oct; 317(4):C800-C812. PubMed ID: 31365289
[TBL] [Abstract][Full Text] [Related]
18. Histochemical visualization of neutral endopeptidase-24.11 (enkephalinase) activity in rat brain: cellular localization and codistribution with enkephalins in the globus pallidus.
Back SA; Gorenstein C
J Neurosci; 1989 Dec; 9(12):4439-55. PubMed ID: 2593007
[TBL] [Abstract][Full Text] [Related]
19. Diffuse enkephalin innervation from caudate to globus pallidus.
Correa FM; Innis RB; Hester LD; Snyder SH
Neurosci Lett; 1981 Aug; 25(1):63-8. PubMed ID: 7279302
[TBL] [Abstract][Full Text] [Related]
20. Elevation of Met-enkephalin-like immunoreactivity in the rat striatum and globus pallidus following the focal injection of excitotoxins.
Ruzicka BB; Jhamandas K
Brain Res; 1990 Dec; 536(1-2):227-39. PubMed ID: 2150770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
